MXPA02012589A - Compuestos utiles para la preparacion de medicamentos con actividad inhibitoria de la fosfodiesterasa iv. - Google Patents
Compuestos utiles para la preparacion de medicamentos con actividad inhibitoria de la fosfodiesterasa iv.Info
- Publication number
- MXPA02012589A MXPA02012589A MXPA02012589A MXPA02012589A MXPA02012589A MX PA02012589 A MXPA02012589 A MX PA02012589A MX PA02012589 A MXPA02012589 A MX PA02012589A MX PA02012589 A MXPA02012589 A MX PA02012589A MX PA02012589 A MXPA02012589 A MX PA02012589A
- Authority
- MX
- Mexico
- Prior art keywords
- medicaments
- preparation
- phosphodiesterase
- inhibitory activity
- compounds useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion se refiere a los compuestos de la formula (I), donde los grupos se definen en la descripcion, asi como tambien procedimientos para su preparacion y su uso como medicamentos, particularmente como inhibidores selectivos de la fosfodiesterasa IV.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2000RM000341A IT1317049B1 (it) | 2000-06-23 | 2000-06-23 | Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv. |
PCT/IT2001/000312 WO2002000593A2 (en) | 2000-06-23 | 2001-06-15 | Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02012589A true MXPA02012589A (es) | 2003-05-14 |
Family
ID=11454800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02012589A MXPA02012589A (es) | 2000-06-23 | 2001-06-15 | Compuestos utiles para la preparacion de medicamentos con actividad inhibitoria de la fosfodiesterasa iv. |
Country Status (13)
Country | Link |
---|---|
US (1) | US7169808B2 (es) |
EP (1) | EP1292563A2 (es) |
JP (1) | JP2004501888A (es) |
KR (1) | KR100764885B1 (es) |
AU (1) | AU2001269420A1 (es) |
CA (1) | CA2411162A1 (es) |
CZ (1) | CZ20023948A3 (es) |
HU (2) | HUP0301205A3 (es) |
IT (1) | IT1317049B1 (es) |
MX (1) | MXPA02012589A (es) |
PL (1) | PL359409A1 (es) |
SK (1) | SK17302002A3 (es) |
WO (1) | WO2002000593A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7312247B2 (en) * | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US8026280B2 (en) * | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7842727B2 (en) | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
WO2003099272A1 (en) | 2002-05-22 | 2003-12-04 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors based on alpha-ketoepoxide compounds |
WO2004046104A2 (en) * | 2002-11-20 | 2004-06-03 | Errant Gene Therapeutics, Llc | Treatment of lung cells with histone deacetylase inhibitors |
EP1707560A4 (en) * | 2003-12-25 | 2007-10-17 | Kureha Corp | HYDROXAMIC ACID DERIVATIVE AND THE DERIVATIVE INHIBITOR OF THE GENERATION OF AGE |
GB0818907D0 (en) * | 2008-10-15 | 2008-11-19 | Isis Innovation | Histone lysine demethylase inhibitors |
SG11202002706XA (en) | 2017-10-05 | 2020-04-29 | Biogen Inc | Process for preparing alpha-carboxamide pyrolidine derivatives |
US20220162164A1 (en) * | 2019-04-10 | 2022-05-26 | Biongen Inc. | Processes for preparing alpha-carboxamide pyrrolidine derivatives |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3714356A (en) * | 1971-01-18 | 1973-01-30 | Morton Norwich Products Inc | Antibacterial composition and method |
GB1419968A (en) | 1972-12-21 | 1975-12-31 | Wyeth John & Brother Ltd | Aziridine derivatives |
AU6889274A (en) * | 1973-05-17 | 1975-11-20 | Astra Laekemedel Ab | Treatment of neurological disorders |
EP0040177B1 (de) * | 1980-05-13 | 1983-07-20 | Ciba-Geigy Ag | Verfahren zur Herstellung von Alkenylbenzol- oder -naphthalincarbonsäurederivaten |
US4820828A (en) * | 1987-03-04 | 1989-04-11 | Ortho Pharmaceutical Corporation | Cinnamohydroxamic acids |
US4971959A (en) * | 1987-04-14 | 1990-11-20 | Warner-Lambert Company | Trisubstituted phenyl analogs having activity for congestive heart failure |
US5232735A (en) * | 1990-06-01 | 1993-08-03 | Bioresearch, Inc. | Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers |
ZW9091A1 (en) | 1990-07-10 | 1992-04-29 | Smithkline Beecham Corp | Oxamides |
US5191084A (en) * | 1991-05-01 | 1993-03-02 | American Home Products Corporation | Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents |
PT100441A (pt) * | 1991-05-02 | 1993-09-30 | Smithkline Beecham Corp | Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso |
US5665754A (en) * | 1993-09-20 | 1997-09-09 | Glaxo Wellcome Inc. | Substituted pyrrolidines |
WO1997005105A1 (en) * | 1995-07-26 | 1997-02-13 | Pfizer Inc. | N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
DE69616357T2 (de) * | 1995-07-26 | 2002-07-11 | Takeda Chemical Industries, Ltd. | Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung |
JP4017214B2 (ja) * | 1996-06-11 | 2007-12-05 | 興和創薬株式会社 | 5−フェニル−3−ピリダジノン誘導体 |
RU2188819C2 (ru) * | 1996-08-12 | 2002-09-10 | Селджин Корпорейшн | НОВЫЕ ИММУНОТЕРАПЕВТИЧЕСКИЕ СОЕДИНЕНИЯ, СОДЕРЖАЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ СНИЖЕНИЯ УРОВНЕЙ ФДЭ, TNFα И NFκB |
GB9618349D0 (en) * | 1996-09-03 | 1996-10-16 | Pharmacia Spa | N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
AR017014A1 (es) * | 1997-07-22 | 2001-08-22 | Astrazeneca Ab | Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos |
IT1294931B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
CA2315370A1 (en) | 1997-12-17 | 1999-06-24 | Merck & Co., Inc. | Integrin receptor antagonists |
US6028116A (en) * | 1998-04-03 | 2000-02-22 | Cell Pathways, Inc. | Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia |
BR9917047A (pt) * | 1998-12-14 | 2002-07-30 | Fujisawa Pharmaceutical Co | Composto de piperazina, método para prepará-lo, composição farmacêutica contendo-o e seu uso |
DE19952146A1 (de) | 1999-10-29 | 2001-06-07 | Boehringer Ingelheim Pharma | Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
-
2000
- 2000-06-23 IT IT2000RM000341A patent/IT1317049B1/it active
-
2001
- 2001-06-15 HU HU0301205A patent/HUP0301205A3/hu unknown
- 2001-06-15 JP JP2002505343A patent/JP2004501888A/ja active Pending
- 2001-06-15 AU AU2001269420A patent/AU2001269420A1/en not_active Abandoned
- 2001-06-15 SK SK1730-2002A patent/SK17302002A3/sk unknown
- 2001-06-15 MX MXPA02012589A patent/MXPA02012589A/es active IP Right Grant
- 2001-06-15 US US10/311,756 patent/US7169808B2/en not_active Expired - Fee Related
- 2001-06-15 HU HU0303399A patent/HUP0303399A3/hu unknown
- 2001-06-15 EP EP01947782A patent/EP1292563A2/en not_active Withdrawn
- 2001-06-15 CZ CZ20023948A patent/CZ20023948A3/cs unknown
- 2001-06-15 WO PCT/IT2001/000312 patent/WO2002000593A2/en active Application Filing
- 2001-06-15 PL PL01359409A patent/PL359409A1/xx not_active Application Discontinuation
- 2001-06-15 KR KR1020027016531A patent/KR100764885B1/ko not_active IP Right Cessation
- 2001-06-15 CA CA002411162A patent/CA2411162A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HUP0301205A2 (hu) | 2003-11-28 |
KR100764885B1 (ko) | 2007-10-09 |
HUP0303399A3 (en) | 2004-10-28 |
ITRM20000341A0 (it) | 2000-06-23 |
WO2002000593A3 (en) | 2002-05-16 |
US7169808B2 (en) | 2007-01-30 |
SK17302002A3 (sk) | 2003-05-02 |
EP1292563A2 (en) | 2003-03-19 |
HUP0303399A2 (hu) | 2004-01-28 |
PL359409A1 (en) | 2004-08-23 |
CZ20023948A3 (cs) | 2003-04-16 |
HUP0301205A3 (en) | 2004-03-01 |
IT1317049B1 (it) | 2003-05-26 |
JP2004501888A (ja) | 2004-01-22 |
ITRM20000341A1 (it) | 2001-12-23 |
WO2002000593A2 (en) | 2002-01-03 |
AU2001269420A1 (en) | 2002-01-08 |
US20030195257A1 (en) | 2003-10-16 |
KR20030012870A (ko) | 2003-02-12 |
CA2411162A1 (en) | 2002-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG151249A1 (en) | 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors | |
MXPA04003795A (es) | Compuestos de pirimidina y composiciones farmaceuticas que contienen los compuestos. | |
WO2003050087A3 (en) | Novel herbicides | |
AP2002002637A0 (en) | Novel piperazine | |
WO2001077107A8 (en) | Oxazole derivatives and their uses as tyrosine kinase inhibitors | |
HK1155146A1 (zh) | 作為藥物活性劑的茚衍生物 | |
SG151250A1 (en) | Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2- quinoxalinones as poly(adp-ribose) polymerase inhibitors | |
PT1159279E (pt) | 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais | |
MXPA02012076A (es) | Compuestos quimicos. | |
MXPA03007142A (es) | Derivados de carbolina. | |
AU2001266575A1 (en) | Chemical compounds | |
MXPA03002911A (es) | Compuestos quimicos. | |
WO2004043362A3 (en) | Acyl guanidine compounds and use thereof | |
ATE297903T1 (de) | Substituierte phenyluracile | |
MXPA02012589A (es) | Compuestos utiles para la preparacion de medicamentos con actividad inhibitoria de la fosfodiesterasa iv. | |
MY136297A (en) | Piperazine derivatives having sst1 antagonistic activity | |
CA2412596A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
CA2356985A1 (en) | 5ht1 antagonists for antidepressant therapy | |
MX9702203A (es) | Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida. | |
SI1377574T1 (es) | ||
ATE251162T1 (de) | Triazolo(4,5-d)pyrimidin-verbindungen | |
BR9713176A (pt) | Benzotiofenos amorfos,métodos de preparação e métodos de uso | |
EP1661898A4 (en) | BICYCLIC PIPERAZINE COMPOUND AND USE THEREOF | |
MXPA02012472A (es) | Compuestos quimicos. | |
EP1203763A3 (de) | Beta-Hydroxyalkylamide, Verfahren zu ihrer Herstellung und deren Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |